Archives: Resources
-
Elsevier: Two-Way Randomized Crossover Study to Establish Pharmacodynamic Bioequivalence Between Oxylanthanum Carbonate and Lanthanum Carbonate
-
ASN ’24 OLC-201-Tolerability-Late-Breaking-Poster
-
ASN ’24 OLC+Tenapanor Combo Study in Rat Poster
-
ASN’24-UNI-494 Phase 1
-
ASN ’24 UNI-494 -Rat IR study Therapeutic
-
Pharmaceutical Chemistry Journal: Systemic Absorption of Oxylanthanum Carbonate is Minimal in Preclinical Models
-
EC Pharmacology and Toxicology: Evaluation of UNI-494 in Acute Kidney Injury Treatment Efficacy When Administered After Ischemia-Reperfusion in a Rat ModelEC Pharmacology and Toxicology
-
ERA ’24 UNI-494 IR Preventative Poster
-
ERA OLC Tenapanor vs OLC Study in Rat
-
ERA Phase 1 Tip-Focused Oral